ArticleLeukemia research2013

Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cell lines supporting its importance in PTCL treatment.

Wenqing Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.